Cancer Vaccines

With ten million persons afflicted each year, no one is entirely immune to cancer and its devastating effects on individuals and families. But recent advances in the development of cancer vaccines—either as therapeutic agents or as preventative measures—are hopeful indicators of progress in this field. This volume comprises invited chapters from world-renowned researchers and clinicians that shed light on recent steps forward in immunotherapeutic and preventive approaches for future cancer vaccines. <p><i>NOTE: Annals volumes are available for sale as individual books or as a journal. For information on institutional journal subscriptions, please visit</i> <a href=”http://www.blackwellpublishing.com/nyas”><u><i>www.blackwellpublishing.com/nyas</i></u></a><i>.</i></p> <p><i>ACADEMY MEMBERS: Please contact the New York Academy of Sciences directly to place your order (</i><a href=”http://www.nyas.org/”><u><i>www.nyas.org</i></u></a><i>). Members of the New York Academy of Science receive full-text access to the Annals online and discounts on print volumes. Please visit <a href=”http://www.nyas.org/MemberCenter/Join.aspx”>http://www.nyas.org/MemberCenter/Join.aspx</a> for more information about becoming a member.</i></p>